Navigation Links
IRIDEX Expands ENT Laser Applications
Date:8/31/2011

MOUNTAIN VIEW, Calif., Aug. 31, 2011 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) announced the introduction of its new XP Module - a high power factory installed option for the IRIDEX IQ 532 green laser system. The IQ 532 XP is a multifunctional device that can be utilized by both ear, nose and throat (ENT) surgeons and ophthalmologists - expanding overall utilization and making a laser investment more attractive.

The optional XP module doubles the power of the standard IRIDEX IQ 532, facilitating the rapid and efficient treatment of tissue while limiting unwanted thermal effects and provides ENT surgeons with a portable KTP 532 nm laser system that is optimized for their clinical needs.

"We developed the XP module in response to the growing demand from ENT surgeons for higher power output, particularly for use when treating laryngeal pathologies," commented Theodore A. Boutacoff, President & CEO. "When used with our family of ENT probes, physicians are now able to expand their treatment capabilities and achieve clinically effective results in less time. The IQ 532 with the XP Module and the IRIDEX family of ENT probes are optimized for the treatment of soft tissue/vascular lesions of the airway and larynx, including polyps and adhesions."

The addition of the XP Module and FlexFiber delivery devices to our existing ENT product line provides additional sales opportunities and demonstrates IRIDEX's dedication to providing physicians with innovative tools to enhance surgical procedures while improving patient and clinical outcomes.

About IQ 532 with XP Module

Our IQ 532 products are small, portable, depot serviced, and efficient solid state semiconductor-based laser systems. Some notable features include a modern touch screen user interface, wireless foot switch control, and voice confirmation. System setup is quick and easy. With the
'/>"/>

SOURCE IRIDEX Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. IRIDEX Introduces New ENT Laser Delivery Devices at AAO-HNSF Annual Meeting
2. IRIDEX Introduces Modular Multi-Wavelength Laser Solution at the American Academy of Ophthalmology
3. IRIDEX Introduces IQ 532 Dual Port Green Laser System at the American Academy of Ophthalmology
4. Ruediger Naumann-Etienne Appointed to IRIDEX Board of Directors
5. IRIDEX Announces Fourth Quarter and Full Year 2009 Conference Call and Release Date
6. IRIDEX Reports Fourth Quarter and Full Year 2009 Financial Results
7. IRIDEX Announces First Quarter 2010 Conference Call and Release Date
8. IRIDEX Announces First Commercial Shipment of New IQ 532(TM) Laser Systems
9. IRIDEX Granted U.S. Patent for Adjustable Laser Probe for Eye Surgery
10. IRIDEX Announces Second Quarter 2010 Conference Call and Release Date
11. IRIDEX Announces Commercial Availability of New Adjustable & Intuitive EndoProbe® Device for Eye Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2, 2014 , ... provide insight into treatment and outcomes of patients ... --   Data from nearly 12,500 ... the FIELD-Atrial Fibrillation (GARFIELD-AF), an innovative, independent academic ... for atrial fibrillation (AF) patients remain sub-optimal despite ...
(Date:9/2/2014)... BARCELONA, Spain , September 2, 2014 ... treatment decisions, including patients, quality of life and treatment ... [ 2 ]   ... ESC Congress 2014, 02 September 2014, ... year results of the PREvention oF thromboembolic events-European Registry ...
(Date:9/2/2014)... CHARLOTTE, N.C. , Sept. 2, 2014 /PRNewswire/ ... today announced a partnership with the American Association ... professional association of respiratory care specialists. Edison Nation ... individuals and small business to commercialize their innovation ... professional association,s community of more than 50,000 respiratory ...
Breaking Medicine Technology:Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 2Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 3Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 4Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 5Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 6Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 7Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 8Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 9One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 2One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 3One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 4One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 5One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 6One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 7One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 8Edison Nation Medical and AARC Team Up To Promote Innovation in Respiratory Care 2Edison Nation Medical and AARC Team Up To Promote Innovation in Respiratory Care 3
... Society of Clinical Oncology,s ... Genitourinary Symposium -, ... (Nasdaq: DNDN ) today presented data,demonstrating the correlation of ... active cellular immunotherapy,for hormone-refractory prostate cancer, with overall survival. This ...
... Confirm the Benefit Avastin Brings to ... Patients With Breast Cancer., BASEL, ... in metastatic breast cancer investigating Avastin,(bevacizumab) in combination with docetaxel chemotherapy ... patients,live without their disease advancing., The findings come from the ...
Cached Medicine Technology:Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival 2Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival 3Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival 4Second Phase III Study of Avastin in 1st Line Metastatic Breast Cancer Meets its Primary Endpoint 2Second Phase III Study of Avastin in 1st Line Metastatic Breast Cancer Meets its Primary Endpoint 3
(Date:9/2/2014)... -- Two new studies further confirm the health benefits ... breast-fed have a lower risk of ear, throat and ... finds a similar trend when it comes to allergies. ... in the immediate newborn period," said Dr. Jennifer Wu, ... City. She was not involved in the new studies. ...
(Date:9/2/2014)... -- Melatonin supplements did not reduce delirium in seniors ... found. Many older hospital patients experience the sudden, ... their normal sleep-wake cycle. A lack of the hormone ... but there has been little research into whether melatonin ... 378 patients, average age 84, who had hip fracture ...
(Date:9/2/2014)... leading group of oncologists has released updated guidelines for ... cancer. HER2-negative breast tumors include cancers that ... the American Society of Clinical Oncology (ASCO) explained Tuesday ... of women with advanced breast cancer have HER2-negative tumors, ... aim is to improve both the length and quality ...
(Date:9/2/2014)... By Steven Reinberg ... (HealthDay News) -- As the Ebola outbreak continues to ... experts from the United States and the United Nations ... stem history,s biggest outbreak of the often-fatal virus. ... Disease Control and Prevention, said that without a greater ...
(Date:9/2/2014)... Doctors trained in locations with less intensive (and expensive) ... clinical decisions that spare patients unnecessary and excessive medical ... Internal Medicine . , "Growing concern about the costs ... assessing physicians, ability to avoid the provision of unnecessary ... Outcomes Group and The Dartmouth Institute for Health ...
Breaking Medicine News(10 mins):Health News:More Evidence Breast-Feeding Lowers Child's Risk of Infections, Allergies 2Health News:New Guidelines for Treating Form of Advanced Breast Cancer 2Health News:More Global Help Needed to Fight Ebola Outbreak 2Health News:More Global Help Needed to Fight Ebola Outbreak 3Health News:Residency training predicts physicians' ability to practice conservatively 2
... , NEW YORK, Aug. 31 You may ... Massapequa, NY is a rare breed. He,s also a rare blood ... dedicated blood donor. , , Make that a VERY ... volunteer whole blood donation, the most on record for New York Blood ...
... FAIRFAX, Va., Aug. 31 The Office of National ... Services (HHS) issued key considerations and challenges for HIE implementation ... Title XIII funding document. , , ... Privacy and security of health information, including ...
... , , PHOENIX, Aug. 31 ... healthcare technology solutions for the ambulatory sector, announced today ... (NHIN), which is being developed to provide a secure, ... others involved in supporting healthcare. Noteworthy was one of ...
... 6 months of age, optometrists say , MONDAY, Aug. ... exam to their children,s back-to-school list, experts say. ... school without ever having an eye examination, even though ... , According to the American Optometric Association,s 2009 survey, ...
... identified a serious and previously misunderstood contaminant that ... into question. In a report published in the ... Leukocyte Biology ( http://www.jleukbio.org ), they show ... blood pressure in ailing patients also contains substances ...
... movie Gattaca, Ethan Hawke stars as a man with "inferior ... future. The 1997 film illustrates the very real fear ... information could be used negatively against us. Last year, ... way DNA data is made publicly available, health institutes in ...
Cached Medicine News:Health News:This Guy's Got Blood, and Heart -- At 320 and Counting, Al Fischer Sets Record for Blood Donations 2Health News:This Guy's Got Blood, and Heart -- At 320 and Counting, Al Fischer Sets Record for Blood Donations 3Health News:This Guy's Got Blood, and Heart -- At 320 and Counting, Al Fischer Sets Record for Blood Donations 4Health News:Edmond Scientific Company Rallies as Certifications & Assessments (C&A) Provider for HIEs Pursuing ARRA-ONC Grants 2Health News:Noteworthy Medical Systems Demonstrates National Health Information Network (NHIN) Interoperability 2Health News:Noteworthy Medical Systems Demonstrates National Health Information Network (NHIN) Interoperability 3Health News:Is Eye Exam on Your Back-to-School List? 2Health News:Are intravenous treatments safe? New research raises doubts 2Health News:Open source DNA 2Health News:Open source DNA 3
The Triage® Parasite Panel is an enzyme immunoassay used for the detection of antigens specific for Giardia lamblia, Entamoeba histolytica/dispar and Cryptosporidium parvum in fresh or freshly fr...
... Urostym™ provides the most current ... including urinary and fecal incontinence. ... easily providing complete patient information ... Customer testimonials have proven Urostym™ ...
... affordable path to Sonesta flexibility. Three ... back adjustments. Packaged with basic accessories, ... of Sonesta add-ons, allowing you to ... needs; complete Sonesta flexibility at an ...
The Triage Drugs of Abuse Panel is the leading rapid drug screen used by U.S. hospitals. The Triage Drugs of Abuse Panel is a small, handheld urine test that provides qualitative results for up to n...
Medicine Products: